Survival Rate Better Among Patients who have Bypass Surgery
Previous results from the same research had raised questions with respect to the benefits of bypass surgery versus medicine alone. Researchers now say that the long-term evidence clearly shows that surgery helps improve survival.
Duke University cardiologist Eric Velazquez, lead author of this study explains that the results are definitive and robust and would definitely lead to stronger recommendation for bypass surgery. Approximately 6 million Americans and 23 million people worldwide suffer from heart failure. Many also have artery disease. Recommendation for bypass surgery have increased in the recent years as well as the use of medicines to ease heart-failure symptoms.
Results after five years of research were published in 2011 and showed an equal number of deaths in bypass patients and in those who received only medicine. 1200 heart failure patients were involved and all were taking heart medicines. Half were assigned to have bypass surgery.
The 10-year results look back at the patients studied and found that 359 bypass patients died from any cause compared with 398 medicine-only patients. Deaths from heart-disease related causes totaled 247 in the bypass group as compared to 297 in the medicine-only group.
In an editorial on the study, it was said that the results provide support for bypass surgery since the long-term results with surgery plus medicine are very encouraging.
Source: New England Journal of Medicine
Image Credit: Wikimedia Commons
Published on : Tue, 5 Apr 2016
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...
The Connex® Spot Monitor features an easy-to-use, vivid touchscreen display and provides accurate vital signs measurement including blood pressure averaging, spot checking, interval monitoring and custom scoring across patient populations. The device...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...